P-Glycoprotein Expression in Acute Myeloblasts Leukemia Analyzed by Immunocytochemistry and Flow Cytometry

References

• Holmes J., Jacobs A., Carter G., Jano wska-Wieczorek A., Padua R.A. Multidrug resistance in haemopoietic cell lines, myelodisplastic syndromes and acute myeloblastic leukemia. Br. J. Haematol 1989; 72: 40–44
   PubMed Web of Science ®Google Scholar
• Ito Y., Tanimoto M., Kumazawa T., Okumuza M., Morishima Y., Ohno R., Saito H. Increased p-glycoprotein expression and multidrug resistant gene (mrd1) amplification are infrequently found in fresh acute leukemia cells. Cancer 1989; 63: 1534–1538
   PubMed Web of Science ®Google Scholar
• Kemnitz J., Freund M., Dominis M., Cohnert T.R., Uysal A., Georgii A. Detection of cells with multidrug-resistance phenotype in myeloproliferative disorders before therapy. Hematologic Pathol. 1989; 3(2)73–78
   PubMedGoogle Scholar
• Mattern J., Efferth T., Bok M., Ho A.D., Volm M. Detection of p-glycoprotein in human leukemias using monoclonal antibodies. Blut 1989; 58: 215–217
   PubMedGoogle Scholar
• Kuwazuru Y., Yoshimura A., Hanada S., Utsunomiya A., Makino T., Ishibashi K., Kodama M., Iwahashi M., Arima T., Akiyama S.I. Expression of the multidrug transporter, p-glycoprotein, in acute leukemia cells and correlation to clinical drug resistance. Cancer 1990; 66: 868–873
   PubMed Web of Science ®Google Scholar
• Sato H., Preisler H., Day R., Raza A., Larson R., Browman G., Goldberg J., Vogler R., Grunwald H., Gottlieb A., Bennett J., Gottesman M., Pastan I. Mdr 1 transcript levels as an indication of resistant disease in acute myelogenous leukaemia. Br. J. Haematol 1990; 75: 340–345
   PubMed Web of Science ®Google Scholar
• Marie J.P., Zittoun R., Sikic B. Multidrug resistance (mdr 1) gene expression in adult acute leukemias: correlations with treatment outcome and in vitro drug sensitivity. Blood 1991; 78(3)586–592
   PubMed Web of Science ®Google Scholar
• Musto P., Melillo L., Lombardi G., Matera R., Di Giorgio G., Carotenuto M. High risk of early resistant relapse for leukaemic patients with presence of multidrug resistance associated p-glycoprotein positive cells in complete remission. Br. J. Haematol. 1991; 77: 50–53
   PubMed Web of Science ®Google Scholar
• Pirker R., Wallner J., Geissler K., Linkesch W., Haas O.A., Bettelheim P., Hopfner M., Scherrer R., Valent P., Havelec L., Ludwig H., Lechner K. Mdr 1 gene expression and treatment outcome in acute myeloid leukemia. J. Natl. Cancer Inst. 1991; 83(10)708–712
   PubMed Web of Science ®Google Scholar
• Michieli M., Damiani D., Geromin A., Michelutti A., Famin R., Raspadori D., Russo D., Visani G., Dinota A., Pileri S., Tsruo T., Grandi M., Baccarani M., Tura S. Overexpression of multidrug resistance-associated pi 70-glycoprotein in acute non-lymphocytic leukemia. Eur. J. Haematol. 1992; 48: 87–92
   PubMed Web of Science ®Google Scholar
• LiQin Y., Gopal V., Kadam P., Files S., Preisler H. The multiple drug resistance gene, mdrl: expression at the protein and ma levels. Med. Oncol. & Tumor Pharmacotherapy 1992; 9(1)3–9
   PubMedGoogle Scholar
• Zhou D., Marie J.P., Suberville A.M., Zittoun R. Relevance of mdrl gene expression in acute myeloid leukemia and comparison of different diagnostic methods. Leukemia 1992; 6(9)879–885
   PubMed Web of Science ®Google Scholar
• Boekhorst P. A. W., Leeuw K., Schoester M., Wittebol S., Nooter K., Hageimejer A., Lowenberg B., Sonneveld P. Predominance of functional multidrug resistance (mdr1) phenotype in CD34+ acute myeloid leukemia cells. Blood 1993; 82(10)3157–3162
   PubMed Web of Science ®Google Scholar
• Miwa H., Kita K., Nishii K., Morita N., Takakura N., Ohishi K., Mahmud N., Kageyoma S., Fukumoto M., Shirakowa S. Expression of mdrl gene in acute leukemia cells: association with CD7+ acute myeloblasts leukemia. Blood 1993; 82(11): 3445–3451
   Web of Science ®Google Scholar
• Tiirikainen M.I., Elonen E., Ruutu T., Jansson S.E., Krusius T. Clinical significance of p-glycoprotein expression in acute leukaemia as analysed by immunocytochemistry. Eur. J. Haematol. 1993; 50: 279–285
   PubMed Web of Science ®Google Scholar
• Piller G.J. Leukaemia research fund international research symposium on cytotoxic drug resistance in leukemia and other malignancies. Leukaemia 1989; 3: 461
   PubMed Web of Science ®Google Scholar
• Waxman D.J. Glutathione-S-Transferases: role in alkylating agent resistance and possible target for modulation chemotherapy. Cancer Res. 1990; 50: 6449–6454
   PubMed Web of Science ®Google Scholar
• Alton P.A. The role of dna topoisomerases II in drug resistance. Br. J. Haematol. 1993; 85: 241–245
   PubMed Web of Science ®Google Scholar
• Danova M., Riccardi A., Sacchi S., Invernizzi R., Palmieri S., Ucci G., Ascari E. New approaches to cancer chemotherapy. Hematol. Rev. 1993, in press
   Google Scholar
• Bennet J.M., Catovski D., Daniel M.T., Flandrin G., Galton D. A. G., Granlick H.R., Sultan C. Proposals for the classification of acute leukemias. Br. J. Haematol. 1976; 33: 451–458
   PubMed Web of Science ®Google Scholar
• Bennet J.M., Catovsky D., Daniel M.T., Flandrin G., Galton D. A. G., Gralnick H.R., Sultan C. Proposed revised criteria for the classification of acute myeloid leukemia. Ann. Int. Med. 1985; 103: 626–632
   PubMedGoogle Scholar
• Boyum A. Separation of leukocytes from blood and bone marrow. Scand. J. Clin. Lab. Invest. 1968; 21(suppl. 97)
   Google Scholar
• Cordell J.L., Falini B., Erber W.N., Ghosh A.K., Abdulaziz Z., McDonald S., Pulford K. A. F., Stein H., Mason D.Y. Immunoenzymatic labelling of monoclonal antibodies using im-munocomplexes of alkaline phosphatase and monoclonal anti alkaline phosphatase (APAAP complexes). J. Histochem. Cytochem. 1984; 32: 219–225
   PubMed Web of Science ®Google Scholar
• Cenciarelli C., Currier S.J., Willingham M.C., Thiebaut F., Germann U.A., Rutherford A.V., Gottesman M.N., Barca S., Tombesi M., Morrone S., Santoni A., Mariani M., Romani C., Dupnis M.L., Cianfriglia M. Characterization by somatic cell genetics of a monoclonal antibody to the mdrl gene product (p-glycoprotein): determination of glycoprotein expression in multidrug-resistant KB and CEM cell variants. Int. J. Cancer 1991; 47: 543–553
   Web of Science ®Google Scholar
• Pollice A.A., McCoy J.P., Shackney S.E., Smith C.A., Agarwal J., Burholt D.R., Janocko L.E., Hornicek F.J., Snigh S.G., Hartsock R.J. Sequential paraformaldehyde and methanol fixation for simultaneous flow cytometric analysis of DNA, cell surface proteins, and intracellular proteins. Cytometry 1992; 13: 432–444
   PubMedGoogle Scholar
• Cowan K.H., Batist G., Tulpule A., Sinha B.K., Myers C. Similar biochemical changes associated with multidrug resistance in human breast cancer cells and carcinogen-induced resistance toxenobiotcs in rats. Proc. Natl. Acad. Sc 1986; 83: 9328–9332
   PubMed Web of Science ®Google Scholar
• Damiani D., Michieli M., Michelutti A., Geromin A., Raspadori D., Fanin R., Savignano C., Giacca M., Pileri S., Mallaroli F., Baccarani M. Expression of multidrug resistance gene (mdr-1) in human normal leukocytes. Haematologica 1993; 78: 12–17
   PubMedGoogle Scholar
• Marie J.P., Brophy N., Ehson M., Aihara Y., Mohamed A., Cornbleet J., Chao N.J., Sikic B.I. Expression of multidrug resistance gene mdrl mRNA in a subset of normal bone marrow cells. Br. J. Haematol 1992; 81: 145–152
   PubMed Web of Science ®Google Scholar